Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |